| |
|
|
| |
Fentanyl
Products, Markets, Strategies and
Opportunities
|
Publication: Nov 2011
Product Code: FNT798K
|
As life expectancy in the developed world increases and
populations age, the incidence and associated morbidity of
chronic and acute pain is increasing and placing a higher
level of emphasis on pain management as a quality-of-life
issue for patients and their families. To address this trend
clinicians are increasingly turning to fentanyl, a narcotic
analgesic significantly more powerful than morphine that is
available in sustained release dosage forms from a number of
drug suppliers. Fentanyl has demonstrated effectiveness
against breakthrough pain and has become a commonly
prescribed pain medication for most forms of cancer.
Controlled release formulations that include transdermal
patches and transmucosal tablets and lozenges help address
the issues of patient safety and prescription narcotic drug
abuse. Pipeline products include oral inhaler and
next-generation spray devices. Annual growth through 2015
will exceed ten percent on a prescription basis, but will be
lower on a revenue basis due to the impact of generics. |
|
Highlights |
· Analyzes and evaluates
fentanyl products and development-stage
candidates
and assesses risks and market potential
· Provides assessments of
pain management markets for fentanyl and examines key
market and commercialization factors
· Evaluates the impact of
economic, technology, and regulatory factors on opioid
pain management markets
· Provides market data
and forecasts to 2015
· Profiles market sector
participants, their product development
activities and business strategies
|
|
Summary of Contents |
Executive Summary
The Current Pain
Management Picture
Unmet Needs in Pain Management
The Opportunity for Fentanyl
The Pain
Management Market Opportunity
Evolution in
Pain Management Guidelines
Regional Factors in
Pain Management Practice
Pain Management Demand
Drivers
Competitive Landscape
Factors
Limiting Growth
Fentanyl Product Formulation
and Device Strategies
Nasal Sprays
Oral
Inhalers
Sublingual/Buccal
Tablets/Lozenges
Sprays
Films
Transdermal Patches
The
Commercial Fentanyl Product Marketspace
FDA-Approved Fentanyl Products
Injectable/Intravenous Fentanyl
Intranasal
Fentanyl
Transdermal Fentanyl
Transmucosal
Fentanyl
Commercial Non-FDA Approved (Non-U.S.)
Fentanyl Products
Intranasal Fentanyl
Transdermal Fentanyl
Transmucosal Fentanyl
The Fentanyl Development Pipeline
Inhaled
Fentanyl Product Candidates
Iontophoretic
Fentanyl Candidates
Transdermal Fentanyl
Candidates
Transmucosal Fentanyl Candidates
Market and Commercialization Factors
Regional Regulations
Clinical Trials
Quality
and Reliability
Indications Prescribing
Guidelines and Off-Label Prescribing
Demand
Picture
Critical Care Hospitals
Clinics and
Ambulatory Care Facilities
Long-term Care
Facilities
Hospice/End-of-Life
Home
Care/Self-Administration
Market Data and
Forecasts
North America
Europe
Other
Geographies
Sector Participant Company Profiles
|
|
|
|
|
